Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CFTR | P13569 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8693634 | 0.87 | KDM4E (0.54) | KDM4EEGLN1ALDH1A1MAPTRECQL | |
| SCHEMBL17634137 | 0.84 | KDM4E (0.51) | KDM4EEGLN1ALDH1A1MAPTRECQL | |
| SCHEMBL8695441 | 0.84 | KDM4E (0.51) | KDM4EEGLN1ALDH1A1RECQLSMN1; SMN2 | |
| SCHEMBL8697079 | 0.83 | KDM4E (0.50) | KDM4EEGLN1ALDH1A1RECQLSMN1; SMN2 | |
| SCHEMBL8693789 | 0.82 | KDM4E (0.49) | KDM4EEGLN1ALDH1A1MAPTRECQL | |
| SCHEMBL31513071 | 0.80 | MAPT (0.48) | ALDH1A1RXFP1NPC1MAPTCFTR | |
| SCHEMBL8694891 | 0.79 | KDM4E (0.67) | KDM4EEGLN1ALDH1A1RXFP1RECQL | |
| SCHEMBL31434094 | 0.74 | ALDH1A1 (0.49) | KDM4EALDH1A1NPC1PDE4BPDE4D | |
| SCHEMBL8694869 | 0.74 | MAPT (0.44) | EGLN1ALDH1A1NPC1PDE4BPDE4D | |
| SCHEMBL17634296 | 0.71 | KDM4E (0.56) | KDM4EEGLN1ALDH1A1MAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5739130-A | TREATING SYSTEMIC LUPUS ERYTHEMATOSIS, MELANOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-04-14 | — | — | US | disclosed |
| US-5583135-A | TREATING SYSTEMIC LUPUS ERYTHEMATOSIS OR MELANOMA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-10 | — | — | US | disclosed |
| EP-0625983-A1 | HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| WO-1993015083-A1 | HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-05 | — | — | WO | disclosed |